valu usd unless otherwis note
view zbh print signal ceo bryan hanson strategi
work capabl sustain growth weight
averag market growth rate wamgr look ahead slightli
increas estim rais price target gain
confid turnaround stori
manag print consensu expect
announc revenu fce y/i
constant currenc rbce exclud extra sell day
think zbh cc growth greater fx neg impact
sale rbce knee sale fce
y/i constant currenc rbce hip sale
fce y/i constant currenc rbce
set report revenu fce
y/i constant currenc rbce spine/cmf revenu
fce y/i constant currenc rbce dental
sale fce y/ constant currenc rbce
report revenu fce
rbce fce y/i
learn call manag reiter guid
expect fx higher end previous announc
guid neg headwind manag state
rosa knee account less half global knee growth
estim translat rosa knee capit revenu
manag state rosa strong demand
rais estim pt rais revenu
vs fce report y/i constant
currenc assum fx neg impact
versu rais adjust dilut
ep vs fce y/i manag
continu anticip margin oper margin expans
assum despit gm pressur howev may give
oper margin expans favor top-lin growth price target
increas
turnaround stori continu right direct manag
believ turnaround take time howev start
see strategi mr hanson implement take hold
highest growth weve seen sinc expect
see wamgr growth quarter howev print
signal compani move right direct new
product launch posit cultur chang improv global suppli
separ manag continu pay debt
open door tuck-in complement zbh core
price prior trade day market close estimate unless otherwis note
believ share outperform
peer group follow key reason
believ world-wide recon market larg stabl
given recent commentari orthoped manag
team well surgeon check believ
world-wide recon market larg stabl fact
world-wide recon market growth remain stabl
y/i rang everi year
expect stabl world-wide recon trend continu
 job outlook overal economi continu
slowli improv price pressur remain constant
y/i rang includ mix
new product drive acceler growth
note sever import new/upcom
product launch acceler top line growth
persona revis system product addit
rosa total knee applic help fuel
organ revenu growth organ growth
turnaround take time zbh oper risk
continu decreas manag process
execut short-term goal cultur
global suppli issu ramp new product launch
pay debt quality/suppli risk decreas
manag abl begin go offens
expect manag slow debt paydown
tuck-in pick combin
new product continu improv suppli give us
confid manag acceler top-line
bloomberg capit market estim upside/downside/target
base case scenario price target assum
compani grow top line line market growth rate
deliv oper margin leverag
peer pro-forma adjust dilut cash ep
estim scenario assum still trade
discount peer analysi support outperform
upsid scenario assum return
top-line growth suppli concern
resolv compani regain surgeon confid
captur market share scenario also assum tuck-in
 acceler manag explor
potenti divestitur sever under-perform busi
includ dental scenario zbh long-term adjust
dilut ep growth could move back line
larg cap md peer group
downsid scenario assum compani
grow top-line market growth rate owe
continu recon share loss on-going pressur
dental bone heal spine busi final call
continu gain recon share robot
overal pure price world-wide recon market
take anoth step scenario zbh long-term
adjust cash ep growth would mid-singl digit y/
large-cap md peer group
perform discount cash flow dcf price-to-earnings ev/ebitda analysi come
intrins valu share departur past practic focus
price-to-earnings multipl believ appropri reflect compani turnaround
cash flow stori deriv price target assign weight
intrins valu calcul dcf analysi weight
intrins valu calcul price-to-earnings analysi weight
intrins valu calcul ev/ebitda analysi assumpt use
analysi includ follow dcf analysi use wacc assum termin
valu ev/ebitda multipl separ assign target forward price-to-earnings multipl
large-cap peer group averag target forward ev/ebitda
multipl large-cap peer group averag believ
share warrant ev/ebitda price-to-earnings multipl overal medic devic
suppli peer group given lower near-term top-lin growth rel peer
uncertainti regard on-going manufacturing/suppli issu price target support
outperform rate
risk rate price target
risk achiev price target rate includ company-specif risk medic
suspens delay launch new product normal industri risk includ
competit depend agent distributor currenc intellectu properti
reimburs slow compani end market clinic trial risk regulatori
inc design develop manufactur market reconstruct
orthopaed implant includ small/larg joint dental spinal implant trauma
product sport medicin product relat orthopaed surgic product
sport extrem trauma
interest expens net
net incom attribut
sport extrem trauma
